Results 181 to 190 of about 35,499 (222)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Acinetobacter spp. and the Clinical Environment
Indoor and Built Environment, 2006Infections associated with Acinetobacter spp. are an increasing problem in hospitals around the world, with many infections being multiply resistant to antibiotics. Acinetobacter spp. are particularly hardy and can survive on dry surfaces for long periods of time. They have also been cultured from the air on hospital wards.
A M Snelling, C B Beggs, P A Sleigh
exaly +2 more sources
Acinetobacter spp. in food and drinking water – A review
Food Microbiology, 2021Acinetobacter spp. has emerged as a pathogen of major public health concern due to their increased resistance to antibiotics and their association with a wide range of nosocomial infections, community-acquired infections and war and natural disaster-related infections.
Carvalheira, Ana +2 more
openaire +3 more sources
Acinetobacter baumannii and Acinetobacter spp.
2017Acinetobacter baumannii is a bacterial pathogen increasingly identified in the clinical microbiology laboratory as a cause of infection in humans. Upon microscopic examination, A. baumannii appears as a Gram-negative coccobacillus, and it produces clear colonies when grown on MacConkey agar, indicating its inability to ferment lactose.
Federico Perez, Robert A. Bonomo
openaire +1 more source
Enrichment of Acinetobacter spp. from food samples
Food Microbiology, 2016Relatively little is known about the role of foods in the chain of transmission of acinetobacters and the occurrence of different Acinetobacter spp. in foods. Currently, there is no standard procedure to recover acinetobacters from food in order to gain insight into the food-related ecology and epidemiology of acinetobacters. This study aimed to assess
Carvalheira, Ana +3 more
openaire +3 more sources
Treatment of Acinetobacter spp. infections
Expert Opinion on Pharmacotherapy, 2003Acinetobacter spp. are predominantly nosocomial pathogens of growing importance. One of their important features is antimicrobial resistance that includes beta-lactams, aminoglycosides and quinolones. Imipenem, considered the most effective drug against Acinetobacter spp., is not universally active against clinical isolates and therapeutic options are ...
openaire +2 more sources
Biodegradation of Carbazole by Newly Isolated Acinetobacter spp.
Bulletin of Environmental Contamination and Toxicology, 2011In this study, two bacterial isolates designated Alp6 and Alp7 were isolated from soil collected from dye industries and screened for their ability to degrade carbazole. Growing cells of the isolates Alp6 and Alp7 could degrade 99.9% and 98.5% of carbazole, respectively in 216 h.
Gajendra B, Singh +3 more
openaire +2 more sources
Hospital infection with Acinetobacter spp.: an increasing problem
Journal of Hospital Infection, 1991During the last few years, among nosocomial pathogens, Acinetobacter spp. have given rise to an increasing number of nosocomial infections. Acinetobacter strains are widely distributed in nature; in hospitals, the human skin is the likely source for most outbreaks of hospital infections.
E, Bergogne-Bérézin, M L, Joly-Guillou
openaire +2 more sources

